CD4+ cells mitochondrial membrane potential in mild and moderate asthma
Abstract
Background. The pathogenetic mechanisms of bronchial asthma (BA) are based on the processes of changes in the cellular energy status and lipid metabolism, the development of hypoxemia, oxidative stress, and systemic inflammation. A reduction in mitochondrial membrane potential (MMP) is manifested even at the early stages of chronic lung diseases development and can be a key pathological sign of their clinical course aggravation.
Purpose. The aim of this study is to investigate the impact of bronchial asthma on the MMP of CD4+ cells, depending on severity and disease control.
Materials and methods. The study included 289 patients with BA, of whom 151 exhibited mild severity and 138 exhibited moderate severity. The control group consisted of 60 volunteers who were deemed to be practically healthy. MMP was quantified using the JC-1 fluorescent dye and monoclonal antibodies for CD4+ identification by flow cytometry. Five distinct levels of MMP were identified. The calculations were performed using the STATISTICA 10.0 software.
Results. A reduction in the total MMP results in a decline in the number of cells exhibiting very high MMP levels, while the number of cells with high and medium MMP levels increases. As the disease progresses and the level of control declines, the total MMP level reduces, accompanied by an increase in the number of CD4+ cells exhibiting reduced and low MMP.
Conclusions. Patients with mild and moderate BA exhibited a pronounced unidirectional change in MMP levels of CD4+ cells, which is dependent on the degree of severity and level of disease control. The assessment of the redistribution of MMP levels of CD4+ cells provides an opportunity for the early detection of energy metabolism disorders in BA, which will allow optimizing the prevention of pathology progression.
EDN: WAAWNE
Downloads
References
References
Denisenko, Y. K., Novgorodtseva, T. P., Vitkina, T. I., Anton'yuk, M. V., & Bocharova, N. V. (2018). Composition of fatty acids in mitochondrial membranes of platelets in chronic obstructive pulmonary disease. Klinicheskaya meditsina, 96(4), 343–347. https://doi.org/10.18821/0023-2149-2018-96-4-343-347
Denisenko, Y. K., Novgorodtseva, T. P., Kondrat'eva, E. V., Zhukova, N. V., Anton'yuk, M. V., Knyshova, V. V., & Mineeva, E. E. (2015). Morpho-functional characteristics of blood cell mitochondria in bronchial asthma. Klinicheskaya meditsina, 93(10), 47–51.
Kondratyeva, E. V., & Vitkina, T. I. (2022). Functional state of mitochondria in chronic respiratory diseases. Bulletin Physiology and Pathology of Respiration, (84), 116–126. https://doi.org/10.36604/1998-5029-2022-84-116-126
Lobanova, E. G., Kondrateva, E. V., Mineeva, E. E., & Karaman, Y. K. (2014). Platelet mitochondrial membrane potential in patients with chronic obstructive pulmonary disease. Klinicheskaya laboratornaya diagnostika, (6), 13–16.
Suprun, E. N. (2022). Assessment of the membrane potential of mitochondria in immunocompetent blood cells of children with asthma, depending on controllability of the course of the disease. Bulletin Physiology and Pathology of Respiration, (86), 50–55. https://doi.org/10.36604/1998-5029-2022-86-50-55
Asher, M. I., Rutter, C. E., Bissell, K., Chiang, C. Y., El Sony, A., Ellwood, E., ... & Pearce, N. (2021). Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study. The Lancet, 398(10311), 1569–1580. https://doi.org/10.1016/S0140-6736(21)01450-1
Bhatti, J. S., Bhatti, G. K., & Reddy, P. H. (2017). Mitochondrial dysfunction and oxidative stress in metabolic disorders - a step towards mitochondria-based therapeutic strategies. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1863(5), 1066–1077. https://doi.org/10.1016/j.bbadis.2016.11.010
Bryant, N., & Muehling, L. M. (2022). T-cell responses in asthma exacerbations. Annals of Allergy, Asthma & Immunology, 129(6), 709–718. https://doi.org/10.1016/j.anai.2022.07.027
Chistiakov, D. A., Shkurat, T. P., Melnichenko, A. A., Grechko, A. V., & Orekhov, A. N. (2018). The role of mitochondrial dysfunction in cardiovascular disease: a brief review. Annals of Medicine, 50(2), 121–127. https://doi.org/10.1080/07853890.2017.1417631
Cloonan, S. M., & Choi, A. M. (2016). Mitochondria in lung disease. Journal of Clinical Investigation, 126(3), 809–820. https://doi.org/10.1172/JCI81113
Farraia, M., Cavaleiro Rufo, J., Paciência, I., Castro Mendes, F., Delgado, L., Boechat, L., & Moreira, A. (2019). Metabolic interactions in asthma. European Annals of Allergy and Clinical Immunology, 51(5), 196–205. https://doi.org/10.23822/EurAnnACI.1764-1489.101
GINA Report, Global Strategy for Asthma Management and Prevention. (2023). Global Initiative for Asthma.
Herrera-de la Mata, S., Ramirez-Suastegui, C., Mistry, H., Castañeda-Castro, F. E., Kyyaly, M. A., Simon, H., ... & Seumois, G. (2023). Cytotoxic CD4+ tissue-resident memory T cells are associated with asthma severity. Medicine, 4(12), 875–897.e8. https://doi.org/10.1016/j.medj.2023.09.003
Jeong, J., & Lee, H. K. (2021). The Role of CD4+ T Cells and Microbiota in the Pathogenesis of Asthma. International Journal of Molecular Sciences, 22(21), 11822. https://doi.org/10.3390/ijms222111822
Moran, G., Buechner-Maxwell, V. A., Folch, H., Henriquez, C., Galecio, J. S., Perez, B., ... & Barria, M. (2011). Increased apoptosis of CD4 and CD8 T lymphocytes in the airways of horses with recurrent airway obstruction. Veterinary Research Communications, 35(7), 447–456. https://doi.org/10.1007/s11259-011-9482-x
Mortimer, K., Lesosky, M., Garcia-Marcos, L., Asher, M. I., Pearce, N., Ellwood, E., ... & Chiang, C. Y. (2022). The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study. European Respiratory Journal, 60(3), 2102865. https://doi.org/10.1183/13993003.02865-2021
Zhu, X., Ji, X., Shou, Y., Huang, Y., Hu, Y., & Wang, H. (2020). Recent advances in understanding the mechanisms of PM2.5-mediated neurodegenerative diseases. Toxicology Letters, 329, 31–37. https://doi.org/10.1016/j.toxlet.2020.04.017
Список литературы
Денисенко, Ю. К., Новгородцева, Т. П., Виткина, Т. И., Антонюк, М. В., & Бочарова, Н. В. (2018). Состав жирных кислот мембран митохондрий тромбоцитов при хронических заболеваниях органов дыхания. Клиническая медицина, 96(4), 343–347. https://doi.org/10.18821/0023-2149-2018-96-4-343-347
Денисенко, Ю. К., Новгородцева, Т. П., Кондратьева, Е. В., Жукова, Н. В., Антонюк, М. В., Кнышова, В. В., & Минеева, Е. Е. (2015). Морфофункциональное состояние митохондрий клеток крови при бронхиальной астме. Клиническая медицина, 93(10), 47–51.
Кондратьева, Е. В., & Виткина, Т. И. (2022). Функциональное состояние митохондрий при хронических респираторных заболеваниях. Бюллетень физиологии и патологии дыхания, (84), 116–126. https://doi.org/10.36604/1998-5029-2022-84-116-126
Лобанова, Е. Г., Кондратьева, Е. В., Минеева, Е. Е., & Караман, Ю. К. (2014). Мембранный потенциал митохондрий тромбоцитов у пациентов с хронической обструктивной болезнью лёгких. Клиническая лабораторная диагностика, (6), 13–16.
Супрун, Е. Н. (2022). Оценка мембранного потенциала митохондрий иммунокомпетентных клеток крови при бронхиальной астме у детей в зависимости от контролируемости течения заболевания. Бюллетень физиологии и патологии дыхания, (86), 50–55. https://doi.org/10.36604/1998-5029-2022-86-50-55
Asher, M. I., Rutter, C. E., Bissell, K., Chiang, C. Y., El Sony, A., Ellwood, E., ... & Pearce, N. (2021). Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study. The Lancet, 398(10311), 1569–1580. https://doi.org/10.1016/S0140-6736(21)01450-1
Bhatti, J. S., Bhatti, G. K., & Reddy, P. H. (2017). Mitochondrial dysfunction and oxidative stress in metabolic disorders - a step towards mitochondria-based therapeutic strategies. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1863(5), 1066–1077. https://doi.org/10.1016/j.bbadis.2016.11.010
Bryant, N., & Muehling, L. M. (2022). T-cell responses in asthma exacerbations. Annals of Allergy, Asthma & Immunology, 129(6), 709–718. https://doi.org/10.1016/j.anai.2022.07.027
Chistiakov, D. A., Shkurat, T. P., Melnichenko, A. A., Grechko, A. V., & Orekhov, A. N. (2018). The role of mitochondrial dysfunction in cardiovascular disease: a brief review. Annals of Medicine, 50(2), 121–127. https://doi.org/10.1080/07853890.2017.1417631
Cloonan, S. M., & Choi, A. M. (2016). Mitochondria in lung disease. Journal of Clinical Investigation, 126(3), 809–820. https://doi.org/10.1172/JCI81113
Farraia, M., Cavaleiro Rufo, J., Paciência, I., Castro Mendes, F., Delgado, L., Boechat, L., & Moreira, A. (2019). Metabolic interactions in asthma. European Annals of Allergy and Clinical Immunology, 51(5), 196–205. https://doi.org/10.23822/EurAnnACI.1764-1489.101
GINA Report, Global Strategy for Asthma Management and Prevention. (2023). Global Initiative for Asthma.
Herrera-de la Mata, S., Ramirez-Suastegui, C., Mistry, H., Castañeda-Castro, F. E., Kyyaly, M. A., Simon, H., ... & Seumois, G. (2023). Cytotoxic CD4+ tissue-resident memory T cells are associated with asthma severity. Medicine, 4(12), 875–897.e8. https://doi.org/10.1016/j.medj.2023.09.003
Jeong, J., & Lee, H. K. (2021). The Role of CD4+ T Cells and Microbiota in the Pathogenesis of Asthma. International Journal of Molecular Sciences, 22(21), 11822. https://doi.org/10.3390/ijms222111822
Moran, G., Buechner-Maxwell, V. A., Folch, H., Henriquez, C., Galecio, J. S., Perez, B., ... & Barria, M. (2011). Increased apoptosis of CD4 and CD8 T lymphocytes in the airways of horses with recurrent airway obstruction. Veterinary Research Communications, 35(7), 447–456. https://doi.org/10.1007/s11259-011-9482-x
Mortimer, K., Lesosky, M., Garcia-Marcos, L., Asher, M. I., Pearce, N., Ellwood, E., ... & Chiang, C. Y. (2022). The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study. European Respiratory Journal, 60(3), 2102865. https://doi.org/10.1183/13993003.02865-2021
Zhu, X., Ji, X., Shou, Y., Huang, Y., Hu, Y., & Wang, H. (2020). Recent advances in understanding the mechanisms of PM2.5-mediated neurodegenerative diseases. Toxicology Letters, 329, 31–37. https://doi.org/10.1016/j.toxlet.2020.04.017
Copyright (c) 2025 Elena V. Kondratyeva, Tatyana I. Vitkina
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
